Jonathan Ozeran

Vice President, Generative AI and Head of Tempus One

2023 - Current

Senior Director of Operations

2022 - 2023

As co-inventor of Tempus One, our AI-enabled clinical assistant, I lead our operational efforts to scale the use of this technology across our oncology provider network to enable precision medicine. Tempus One gives clinicians easier access to molecular and clinical data and improves their ability to make data-driven treatment decisions on behalf of their patients. It leverages our vast healthcare dataset, which now exceeds 100 petabytes of curated data, and uses pioneering advancements in generative AI to place our precision medicine platform at the fingertips of every clinician we serve. https://www.tempus.com/oncology/tempus-one/

Director of Product

2016 - 2022

As Director of Product, I created and led the clinical data structuring program which includes the development of advanced tools and technologies to convert text buried inside oncology notes, pathology reports, and radiology reports into structured data that can be used for research, analysis, quality metrics reporting and clinical decision support. A team of trained abstractors use a custom toolset, optical character recognition (OCR), natural language processing (NLP) tools, and automation to structure, clean and standardize data.
 https://www.tempus.com/clinical-data-structuring/ Additionally, I created and led the product development for our clinical trial matching program that allows a patient’s sequenced molecular data and clinical history to be compared against participating trials structured inclusion and exclusion criteria through our proprietary trial matching software and methods. This technology is used in support of the TIME Trial Program, a just-in-time network of providers to support rapid patient identification, site activation, and enrollment of select clinical trials. Through the TIME Trial Program, 2,600 oncologists and their patients have unprecedented access to a large portfolio of cutting-edge precision medicine trials.
 https://www.tempus.com/clinical-trial-matching/

Angel Investor

2020

Particular interests in: Digital Health, Life Science, Enterprise SaaS, AI / ML Dev Tools, Wealth Tech & XR Select Investments: Brave Care, Cabinet Health, Mate Fertility, Milu Health, Natrion, NextGem, PatchRx, ShapesXR, Spaero Bio, Sandhill Markets, Trala, Tribe XR

Advisor

2021

Sandalphon invests in B2B and Consumer startups in Pre-Seed to Series A rounds as a lead, co-lead or meaningful investor. They are primarily focused on the Midwest but invest across North America.

Venture Partner

2021

Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology startups that have a positive impact on the world.

Advisor

2017

Great North Ventures is an early-stage venture fund focused on cultivating the next generation of tech startups across the Upper Midwest. Great North Labs closed its first fund with $23.7M in committed capital. The fund is based in St. Cloud and Minneapolis, Minnesota, with a partner located in Silicon Valley.

Advisor

2017

ShoppingGives encourages consumers to make an impact through its change commerce technology.

Advisor

2020

Inhabitr is a furniture rental platform that lets users rent furniture at an affordable price.

Advisor

2022

Bitewell is a healthy food marketplace that works directly with employers to provide food health benefits, reducing insurance premiums and improving health for users.

Advisor

2021

Benefunder provides personalized philanthropic and investment banking services to help private funders execute their impact mandates.

Adjunct Lecturer

2013 - 2017

Taught courses as part of several graduate and undergraduate programs focused on mobile product design & prototyping and software engineering with the MEAN software stack (MongoDB, Express.js, Angular.js & Node.js).